← Evidence map

ArticleOncogene2021

Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes.

Timofey Lebedev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34556815